These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7059179)

  • 1. NH2-terminal sequences of DNA-, heparin-, and gelatin-binding tryptic fragments from human plasma fibronectin.
    Pande H; Shively JE
    Arch Biochem Biophys; 1982 Jan; 213(1):258-65. PubMed ID: 7059179
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
    Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
    J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two plasma fibronectin fragments with different gelatin-binding properties.
    Griffin CA; Calaycay J; Shively JE; Smith RL
    Thromb Res; 1986 Aug; 43(4):469-77. PubMed ID: 3532418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalent cation modulation of fibronectin binding to heparin and to DNA.
    Hayashi M; Yamada KM
    J Biol Chem; 1982 May; 257(9):5263-7. PubMed ID: 6802851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential proteolytic activity of human plasma fibronectin: fibronectin gelatinase.
    Planchenault T; Lambert Vidmar S; Imhoff JM; Blondeau X; Emod I; Lottspeich F; Keil-Dlouha V
    Biol Chem Hoppe Seyler; 1990 Feb; 371(2):117-28. PubMed ID: 2159309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain.
    Garcia-Pardo A; Pearlstein E; Frangione B
    J Biol Chem; 1983 Oct; 258(20):12670-4. PubMed ID: 6630202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdomain cleavage of plasma fibronectin by zinc-metalloproteinase from Serratia marcescens.
    Molla A; Tanase S; Hong YM; Maeda H
    Biochim Biophys Acta; 1988 Jun; 955(1):77-85. PubMed ID: 3289620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inaccessibility to ligands of the amino-terminal region of plasma fibronectin.
    Homandberg GA
    Thromb Res; 1987 Nov; 48(3):321-7. PubMed ID: 3433256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of extracellular fibronectin matrix formation with fluoresceinated fibronectin and fibronectin fragments.
    Chernousov MA; Metsis ML; Koteliansky VE
    FEBS Lett; 1985 Apr; 183(2):365-9. PubMed ID: 3921405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alignment of biologically active domains in the fibronectin molecule.
    Ruoslahti E; Hayman EG; Engvall E; Cothran WC; Butler WT
    J Biol Chem; 1981 Jul; 256(14):7277-81. PubMed ID: 6788765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional comparisons of chicken and human cellular fibronectins.
    Bernard BA; Akiyama SK; Newton SA; Yamada KM; Olden K
    J Biol Chem; 1984 Aug; 259(15):9899-905. PubMed ID: 6146622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
    Zhu BC; Fisher SF; Pande H; Calaycay J; Shively JE; Laine RA
    J Biol Chem; 1984 Mar; 259(6):3962-70. PubMed ID: 6423638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding fibronectin fragments containing cell-binding domains and devoid of hep2 and gelatin-binding domains promote human embryo fibroblast proliferation.
    Zlatopolsky AD; Chubukina AN; Berman AE
    Biochem Biophys Res Commun; 1992 Mar; 183(2):383-9. PubMed ID: 1372500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin: multiple interactions assigned to structural domains.
    Vartio T
    Med Biol; 1983; 61(6):283-95. PubMed ID: 6374309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylation of gelatin-agarose and the enhancement by heparin of fibronectin binding.
    Smith RL; Griffin CA
    Arch Biochem Biophys; 1988 Oct; 266(1):181-8. PubMed ID: 3178220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain structure of the carboxyl-terminal half of human plasma fibronectin.
    Hayashi M; Yamada KM
    J Biol Chem; 1983 Mar; 258(5):3332-40. PubMed ID: 6826564
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity.
    Garcia-Pardo A; Rostagno A; Frangione B
    Biochem J; 1987 Feb; 241(3):923-8. PubMed ID: 3593230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
    Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L
    Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary structure of a glycosylated DNA-binding domain in human plasma fibronectin.
    Pande H; Calaycay J; Hawke D; Ben-Avram CM; Shively JE
    J Biol Chem; 1985 Feb; 260(4):2301-6. PubMed ID: 3882691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.